We gratefully thank all our wonderful Keynote Speakers, Speakers, Conference Attendees, Students, Organizing Committee Members and Associations for making Rare Diseases 2021 Conference the best ever. Firstly, we are thankful to you for trusting us and a part of the Rare Diseases 2021, a global platform to discuss various important aspects of Rare Diseases and Orphan Drugs. There are infinite reasons to extend our gratitude to all our supporters for making the Rare Diseases 2021 a great conference. We couldn’t have done it without your continuous support and believe towards our organization, which mutually made to achieve Rare Diseases 2021 a new height in the field of healthcare. The conference was manifest with the presence of global experts both from academia and industries, young and brilliant researchers, business & academic delegates and student communities from more than 25 countries, who have driven this conference into the path of success. Rare Diseases 2021 was based on the theme “Delivering Innovative Therapies to Patients with Rare Diseases”

The conference was initiated with the Honourable presence of the Speakers.

Talk 1: Bacterial resistance, the global threat by Mohamed Sabri Youssef | Mansoura University, Egypt
Talk 2: A specific criteria-based guideline improves compliance with general
surgery ambulatory care standards and reduces overcrowding in “Hot Clinic”: A closed-loop prospective clinical audit by Ketevan Papidze | Ysbyty Glan Clwyd, UK
Talk 3: Plasminogen drug product stability study for intended use in ligneous
conjunctivitis,  Alfonso Salvatorea| Kedrion Biopharma, Italy
Talk 4: Total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery: Meta-analysis of survival and functional outcomes by Nisha Mallya,
|Ysbyty Glan Clwyd, UK
Talk 5: Rectal perforation and necrosis associated with fleet enema: Two rare case Chi Fai Tsang | Prince of Wales Hospital | Australia
Talk 6: The operative management of gallstone ileus – The unanswered question Chi Fai Tsang | Prince of Wales Hospital | Australia
Talk 7: The potential role and impact of patients, advocates, and caregivers on medical publications and acceptance of treatments in rare diseases Mukund Nori | RareLife solutions | USA
Talk 8: Microbiology and infectious diseases Jorge Trujillo Mendoza | Private practice| Mexico
Talk 9: Head of department of infectious and tropical diseases Abdifatah Ahmed Mohamed |National University | Somalia
Talk 10: Unique patient identification as a necessary condition for clinical research in rare diseases Alex Sherman | Massachusetts General Hospital | USA

The supporting journals include: Advances in Rare Diseases and Journal of Rare Diseases: Research and Treatment.